688056 莱伯泰科
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.8144.9634.6973.2895.533
总资产报酬率 ROA (%)0.7104.2723.9942.8044.814
投入资产回报率 ROIC (%)0.7694.6184.3153.0375.193

边际利润分析
销售毛利率 (%)47.06445.30245.54143.79147.709
营业利润率 (%)8.11611.56010.3176.84314.447
息税前利润/营业总收入 (%)6.49310.6109.5576.05613.769
净利润/营业总收入 (%)7.62210.0729.2336.62612.570

收益指标分析
经营活动净收益/利润总额(%)79.67083.105101.67895.04991.008
价值变动净收益/利润总额(%)14.8699.74611.10112.89410.298
营业外收支净额/利润总额(%)1.155-0.525-0.024-0.108-0.184

偿债能力分析
流动比率 (X)6.9276.3265.7425.3775.958
速动比率 (X)5.2274.8674.4674.2424.760
资产负债率 (%)12.28513.37714.45215.44814.025
带息债务/全部投入资本 (%)4.4205.7387.1597.8466.193
股东权益/带息债务 (%)2,151.9311,634.4861,289.7511,165.1681,506.360
股东权益/负债合计 (%)713.993647.529591.925547.333613.024
利息保障倍数 (X)-3.781-11.929-12.615-7.775-21.166

营运能力分析
应收账款周转天数 (天)56.83048.89145.81545.23448.089
存货周转天数 (天)356.096284.693264.144249.917249.236